Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 9, 1997

View Archived Issues

Galderma develops novel compounds active on cell differentiation and proliferation

Pharmacia & Upjohn describes selective 5-HT2 antagonists

High-affinity inhibitor of biogenic amine transporters described

KGF receptor antagonists developed by U.S. researchers

Potential HIV-1 therapy disclosed by Houghten

Novel antitumor/immunomodulatory agents isolated by Japanese investigators

Keoprofen generic approval

FDA approves new HIV 1/2 test

Alendronate reduces occurrence of vertebral fractures in Fracture Intervention Trial

ISIS-2302 update

Study results reported for Genentech AIDS vaccine candidate

Ciclosporin bioequivalency established

ALRT announces new additions to the product pipeline

Gene discovery collaboration announced

Vion receives SBIR grant to develop ribonucleotide reductase inhibitor

Cariel trial initiated

GeneMedicine to begin phase I testing of IGF-I Gene Medicine

P&U files for European approval of urinary incontinence Rx

OXiGENE and Boston Medical Center announce collaboration

EchoGen submitted for European regulatory review

Orphan drug designation granted for NeuroCell-PD, NeuroCell-HD

Progress in Sugen's cancer development pipeline

Drug discovery collaboration agreement signed by Houghten, Chugai

Progenitor's functional genomics program advances

SKB/WRAIR malaria vaccine shown effective in clinical challenge trial

New insights into melanocortin role in obesity

ICOS-Suntory j.v. to develop rPAF-AH

CCD-1042 progresses in trials

VIMRxyn enters clinical testing in HCV-infected patients

QLT, AHP redefine Photofrin relationship

Three new melanoma vaccines from Therion Biologics enter clinical testing

Sequana and Glaxo Wellcome alliance

Company Profile: Epoch Pharmaceuticals

Protease inhibitor review published

Annual review of Ibex Technologies' product pipeline

AmBisome receives 25th approval/DaunoXome receives 17th approval

Positive phase III trial results reported for phosphate binder

Viracept now available to children

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...